Judah Folkman

Boston Children's Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

158h-index136.8kcitations555works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(262), Cancer, Hypoxia, and Metabolism(128), Cell Adhesion Molecules Research(53), Proteoglycans and glycosaminoglycans research(31), Cancer, Lipids, and Metabolism(31)

Publications553 total

Tumour Angiogenesis
2023· 3 cited
Supplementary Methods and Figure Legends from Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors
2023Open Access
Data from Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors
2023Open Access
Data from Regional Control of Tumor Growth
2023Open Access
Supplementary Data from Regional Control of Tumor Growth
2023Open Access
Supplementary Data from Regional Control of Tumor Growth
2023Open Access
Supplementary Methods and Figure Legends from Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors
2023Open Access
Supplementary Figures 1 through 3 from Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors
2023Open Access
Supplementary Figures 1 through 3 from Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors
2023Open Access
Data from Regional Control of Tumor Growth
2023Open Access
Data from Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors
2023Open Access
Supplementary Figure 2 from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Supplementary Figure Legends 1-3 from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Supplementary Figure 1 from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Supplementary Figure 1 from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Data from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Supplementary Figure Legends 1-3 from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Supplementary Figure 3 from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Data from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
Supplementary Figure 3 from Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
2023Open Access
page 1 of 28Next →

Frequent Co-authors

Michael Klagsbrun(5), Michael S. O’Reilly(3), Yuen Shing(3), Evelyn Flynn(3), Israël Vlodavsky(3), Michael A. Gimbrone(3), Ramzi S. Cotran(3), Douglas Hanahan(2), Noel Weidner(2), Thomas Boehm(2), Robert J. D’Amato(2), Róbert Langer(2), R. Alan B. Ezekowitz(2), John B. Mulliken(2), Christian C. Haudenschild(2), Robert Sullivan(2), Joachim Sasse(2), Kashi Javaherian(2), Kin-Ming Lo(2), Catherine Butterfield(2)